Cogentin
PubChem Notes:
Benztropine A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.
Molecular Formula:
C22H29NO4S
InChI: InChI=1/C21H25NO.CH4O3S/c1-22-18-12-13-19(22)15-20(14-18)23-21(16-8-4-2-5-9-16)17-10-6-3-7-11-17;1-5(2,3)4/h2-11,18-21H,12-15H2,1H3;1H3,(H,2,3,4)/t18-,19-;/m1./s1/f/h;2H
InChIKey: InChIKey=CPFJLLXFNPCTDW-SEMYEPHVDS
SMILES: CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O
Names:
Benzatropine methanesulfonate
Benzotropine mesylate
Benzotropine methanesulfonate
Benztropine mesilate
BENZTROPINE MESYLATE
Benztropine methanesulfonate
Cobrentin methanesulfonate
Cogentin
MK 02
(1R,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; methanesulfonic acid
3-Diphenylmethoxytropane mesylate
Registries:
PubChem CID 8584
PubChem ID 151740
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|